Nasdaq

Medtronic InterStim System Shows Five-Year Positive Results

One of the world's largest medical technology, services and solutions companies, Medtronic plc MDT is making efforts to expand its Pelvic Health & Gastric Therapies business, part of the company's ...
Yahoo Finance

FDA Approves Smart Programmer for the InterStim System

Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence DUBLIN - December 17, 2018 - Medtronic plc (MDT) today announced U.S. Food and Drug ...
WWLP-22News

Medtronic receives FDA approval for InterStim X™ system, the next generation of the most personalized sacral nerve stimulation therapy for bladder and bowel control

DUBLIN, Feb. 22, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it received approval from the U.S. Food and Drug Administration (FDA) for ...
EurekAlert!

University Hospitals OBGYN and urologist Joseph Welles Henderson, MD, named InterStim™ Center of Excellence

Joseph Welles Henderson, MD, of University Hospitals has been named an InterStim™ Center of Excellence by Medtronic (NYSE: MDT), the world’s largest medical device manufacturer. The designation is ...
Nasdaq

Axonics® Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim II

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ...
Yahoo Finance

Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System

DUBLIN, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has begun recruitment of the prospective, multicenter, global, ...
Investing

Medtronic InterStim System Shows Five-Year Positive Results

One of the world’s largest medical technology, services and solutions companies, Medtronic plc (NYSE:MDT) is making efforts to expand its Pelvic Health & Gastric Therapies business, part of the ...
Finanznachrichten

Axonics Modulation Technologies, Inc.: Axonics Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim II

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of ...